Tafasitamab with lenalidomide not recommended
SMC does not recommend tafasitamab with lenalidomide for R/R DLBCL
News
Read the latest news and views from Lymphoma Action.
Use the drop down filter to find the most relevant news for you.
Look after your mental health
Raising awareness of anxiety this Mental Health Awareness Week
Thank you to our Bridges of London walkers!
Over 300 supporters took part in our Bridges of London event on Sunday to support our work!
International Nurses Day 2023
Today is a chance to say thank you to all nurses caring for people with lymphoma.
Dying Matters Week 2023
Dying Matters encouraging communities to talk about death, dying and grief.
It’s national walking month!
Support our work by donning your walking shoes and getting involved in our Bridges of Britain walk!
Listen to our latest podcast
John's incredible lymphoma story began nearly 50 years ago.
Join our Living well on active monitoring webinar
On Thursday 25 May from 12.30pm to 1.30pm
It’s important to protect your skin – even in the UK
Raising awareness of sun protection this Sun Awareness Week.
Latest guidance from NICE
NICE recommends new treatments for CLL and DLBCL but treatments for follicular lymphoma not recommended